Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insys Therapeutics Inc.

www.insysrx.com

Latest From Insys Therapeutics Inc.

Execs On The Move, August 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Express Scripts Boosts Formulary Exclusions With Focus On Multi-Source Brands

Pharmacy benefit manager adds 64 drugs to its list of formulary exclusions for 2018, bringing to 159 the number designated as not covered.

Pricing Strategies Pricing Debate

Advaxis Zips Listeria/Opdivo Combo Straight To Registrational Cervical Cancer Trial

Potentially registrational trial of ADXS-DUAL Listeria-based vaccine with Bristol's PD-1 inhibitor Opdivo in recurrent metastatic cervical cancer will complement Advaxis's adjuvant study of earlier-generation candidate axalimogene filolisbac.

Research & Development ImmunoOncology

GW's Epidolex Epilepsy Data Paves Way For Cannabinoids

Safety and efficacy in study published in New England Journal of Medicine bode well for cannabinoid therapy Epidiolex, which is headed to FDA mid-year.

Neurology Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Insys Therapeutics Inc.
  • Senior Management
  • N L Kapoor John, Pres. & CEO
    Andrew G Long, CFO
    Larry Dillaha, MD, CMO
  • Contact Info
  • Insys Therapeutics Inc.
    Phone: (602) 910-2617
    10220 S. 51st St.
    Ste. 2
    Phoenix, AZ 85044
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register